On the contrary, in advanced stages of AD pathology characterized by hyperproduction of pro-inflammatory cytokines in response to Tau phosphorylation and alteration of ApoE expression, for instance, the anti-inflammatory function of miRNA-146a-5p might be countered by multiple upstream signaling events activated by these inflammatory mediators of AD pathology. This evidence concerns the gene APOE and Alzheimer disease.